Skip to main content
SpringerLink
Log in

Ventricular Tachycardia: A Rare Side Effect of Voriconazole

  • Scientific Letter
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Lehrnbecher T, Phillips R, Alexander S, et al; International Pediatric Fever and Neutropenia Guideline Panel. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2012;30:4427–38.

  2. Lewis RE. What is the "therapeutic range" for voriconazole? Clin Infect Dis. 2008;46:212–4.

    Article  CAS  PubMed  Google Scholar 

  3. Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J. 2002;21:240–8.

    Article  PubMed  Google Scholar 

  4. Neely M, Rushing T, Koovacs A, Jelliffe R, Hoffman J. Voriconazole pharmacokinetics and pharmacodynamics in children. Clin Infect Dis. 2010;50:27–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Uludağ D, Ozdemir N, Tüysüz G, Eroğlu AG, Celkan T. Voriconazole induced bradycardia. Pediatr Hematol Oncol. 2013;30:674–6.

    Article  PubMed  Google Scholar 

  6. Perbet S, Blondonnet R, Guérin R, Cayot-Constantin S, Constantin JM. Voriconazole-induced bradycardia without QT interval prolongation: a possible non-concentration-dependent adverse effect. Intensive Care Med. 2013;39:531–2.

    Article  PubMed  Google Scholar 

  7. Zeuli JD, Wilson JW, Estes LL. Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients. Antimicrob Agents Chemother. 2013;57:1121–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. De Ponti F, Polluzi E, Cavelli A, Recanatini M, Montanaro N. Safety of non-arrhythmogenic drugs that prolong the QT interval or induce torsedo de pointis. Drug Saf. 2002;25:263–86.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, 110095, India

    Pooja Dewan, Sunil Gomber & Vanny Arora

Authors
  1. Pooja Dewan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunil Gomber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vanny Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pooja Dewan.

Ethics declarations

Conflict of Interest

None.

Source of Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dewan, P., Gomber, S. & Arora, V. Ventricular Tachycardia: A Rare Side Effect of Voriconazole. Indian J Pediatr 84, 152–153 (2017). https://doi.org/10.1007/s12098-016-2217-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-016-2217-9

Keywords

Search

Navigation